Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
2.345
+0.085 (3.76%)
Nov 21, 2024, 12:56 PM EST - Market open

Oramed Pharmaceuticals Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for ORMP.

Analyst Consensus: Hold
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

According to 1 stock analyst, the rating for ORMP is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 000000
Buy 000000
Hold 111111
Sell 000000
Strong Sell 000000
Total 111111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
n/a
Hold Reiterates n/a n/a Sep 9, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
n/a
Hold Reiterates n/a n/a May 20, 2024
Canaccord Genuity
Canaccord Genuity
Hold
Maintains
$3$2
Hold Maintains $3$2 -14.71% May 17, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Jan 17, 2023
Canaccord Genuity
Canaccord Genuity
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Jan 12, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 1.34M
Revenue Next Year
1.02M
EPS This Year
0.24
from 0.14
Increased by 78.63%
EPS Next Year
-0.08
from 0.24
Fiscal Year FY 2020 FY 2021 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Period Ending Dec 31, 2020 Aug 31, 2021 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025
Revenue
2.71M2.70M2.71M2.70M1.34M-1.02M
Revenue Growth
0.07%-0.33%0.33%-0.33%-50.43%--
EPS
-0.90-0.78-0.94-0.940.140.24-0.08
EPS Growth
-----78.63%-
Forward PE
-----9.58-
No. Analysts -----44
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025
High n/a 2.1M
Avg n/a 1.0M
Low n/a n/a

Revenue Growth

Revenue Growth 20242025
High - -
Avg - -
Low - -

EPS Forecast

EPS 20242025
High 0.33 0.11
Avg 0.24 -0.08
Low 0.17 -0.25

EPS Growth

EPS Growth 20242025
High
137.5%
-57.1%
Avg
78.6%
-
Low
21.6%
-
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.